COMMUNIQUÉS West-GlobeNewswire
-
Rejuveron Life Sciences AG Rebrands as Centenara Labs AG and Provides Latest Clinical Updates
19/09/2024 - 16:00 -
GUERBET : Nombre d'actions et de droits de vote composant le capital de la société au 31 août 2024
19/09/2024 - 16:04 -
Thought Leadership & Innovation Foundation Announces Partnership with Paradigm to Support Limb Loss and Preservation Registry
19/09/2024 - 16:20 -
LinkGevity Awarded Deep-Tech EU Grant
19/09/2024 - 10:00 -
ITM to Present at Upcoming Radiopharmaceutical Investor Conferences in New York City
19/09/2024 - 11:22 -
BioRestorative Therapies’ IFATS 2024 Presentation to Feature ThermoStem® Platform’s Potential to Deliver a Superior Efficacy and Tolerability Profile Over GLP-1 Drugs
19/09/2024 - 12:55 -
Dr. Paulo Fontoura, MD, PhD, joins STALICLA as Chief Scientific and Clinical Development Advisor
19/09/2024 - 13:00 -
Tiziana Life Sciences Announces $4 Million Grant Awarded by National Institutes of Health to Study Anti-CD3 in Alzheimer’s Disease
19/09/2024 - 13:00 -
Vivos Therapeutics Announces Pricing of $4.3 Million Registered Direct Offering of Common Stock Priced At-The-Market Under Nasdaq Rules
19/09/2024 - 13:00 -
Achilles Therapeutics Announces Strategic Update
19/09/2024 - 13:00 -
ACELYRIN, INC. Announces Positive Results from Global Phase 3 Clinical Trial of Izokibep in Hidradenitis Suppurativa to be Highlighted in Late-Breaking Oral Presentation at EADV 2024
19/09/2024 - 13:00 -
BioXcel Therapeutics Announces Clinical Prioritization and Update on BXCL501 Late-Stage Programs for Agitation
19/09/2024 - 13:00 -
Tonix Pharmaceuticals Announces Issuance of U.S. Patent by the United States Patent and Trademark Office Covering the Intranasal Delivery of FDA-Approved Tosymra® to Treat Migraines
19/09/2024 - 13:00 -
Gain Therapeutics to Present Preclinical GT-02287 Data in Parkinson’s Disease Models Including Two Late-Breakers at Neuroscience 2024
19/09/2024 - 13:00 -
Larimar Therapeutics Announces Three Poster Presentations at the Upcoming International Congress for Ataxia Research
19/09/2024 - 13:00 -
Lifecore Biomedical Announces High-Speed, Multi-Purpose 5-Head Isolator Filler is GMP-Ready and Operational
19/09/2024 - 13:00 -
Shock Top Announces its Official Craft Beer Sponsorship of University of Missouri Athletics
19/09/2024 - 13:12 -
Addex Provisional 2024 Half-Year and Second Quarter Result increased from a Net loss to a Net Profit
19/09/2024 - 07:00 -
Positive phase III results show Xofluza significantly reduces the transmission of influenza viruses
19/09/2024 - 07:00
Pages